Literature DB >> 23528982

Deletion of miRNAs in bone marrow prevents streptozotocin-induced murine autoimmune diabetes but deletion of miR-155 does not.

Wen-Bin Chen, Ling Gao, Matthew Weiland, Jiajun Zhao, Min Liu, Li Zhou, Qing-Sheng Mi.   

Abstract

Entities:  

Keywords:  Dicer; knockout mouse; miRNAs; mir-155; streptozotocin; type 1 diabetes

Mesh:

Substances:

Year:  2013        PMID: 23528982      PMCID: PMC3646871          DOI: 10.4161/cc.24365

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  9 in total

1.  Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice.

Authors:  Lei Tian; Gert De Hertogh; Maya Fedeli; Kim A Staats; Susann Schonefeldt; Stephanie Humblet-Baron; Ludo Van Den Bosch; Paolo Dellabona; James Dooley; Adrian Liston
Journal:  J Autoimmun       Date:  2012-01-04       Impact factor: 7.094

2.  Loss of microRNAs in thymus perturbs invariant NKT cell development and function.

Authors:  Kook-Heon Seo; Li Zhou; Dongmei Meng; Jianrui Xu; Zhong Dong; Qing-Sheng Mi
Journal:  Cell Mol Immunol       Date:  2010-09-20       Impact factor: 11.530

3.  Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.

Authors:  Susan Kohlhaas; Oliver A Garden; Cheryl Scudamore; Martin Turner; Klaus Okkenhaug; Elena Vigorito
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 4.  MicroRNAs and immune regulatory T cells.

Authors:  Li Zhou; Kook Heon Seo; Henry K Wong; Qing-Sheng Mi
Journal:  Int Immunopharmacol       Date:  2009-01-29       Impact factor: 4.932

Review 5.  MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function.

Authors:  Li Zhou; Jang-June Park; Quanhui Zheng; Zheng Dong; Qingsheng Mi
Journal:  Cell Mol Immunol       Date:  2011-08-08       Impact factor: 11.530

6.  MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development.

Authors:  Ryan M O'Connell; Daniel Kahn; William S J Gibson; June L Round; Rebecca L Scholz; Aadel A Chaudhuri; Melissa E Kahn; Dinesh S Rao; David Baltimore
Journal:  Immunity       Date:  2010-09-30       Impact factor: 31.745

7.  Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development.

Authors:  Li Zhou; Kook-Heon Seo; Hong-Zhi He; Rafal Pacholczyk; Dong-Mei Meng; Chang-Gui Li; Jianrui Xu; Jin-Xiong She; Zheng Dong; Qing-Sheng Mi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-09       Impact factor: 11.205

8.  Aberrant T cell differentiation in the absence of Dicer.

Authors:  Stefan A Muljo; K Mark Ansel; Chryssa Kanellopoulou; David M Livingston; Anjana Rao; Klaus Rajewsky
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

9.  A role for Dicer in immune regulation.

Authors:  Bradley S Cobb; Arnulf Hertweck; James Smith; Eric O'Connor; Daniel Graf; Terence Cook; Stephen T Smale; Shimon Sakaguchi; Frederick J Livesey; Amanda G Fisher; Matthias Merkenschlager
Journal:  J Exp Med       Date:  2006-10-23       Impact factor: 14.307

  9 in total
  4 in total

1.  microRNA-340 influences cell proliferation, apoptosis and invasion by targeting NF-κB1 in gastric cancer.

Authors:  Qi Chen; Yugao Zhang; Liping Xu
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  High glucose increases LPS-induced DC apoptosis through modulation of ERK1/2, AKT and Bax/Bcl-2.

Authors:  Mei Feng; Juan Li; Jun Wang; Chunyan Ma; Yulian Jiao; Yan Wang; Jie Zhang; Qiuying Sun; Ying Ju; Ling Gao; Yueran Zhao
Journal:  BMC Gastroenterol       Date:  2014-05-28       Impact factor: 3.067

3.  miR-155 is dispensable in monosodium urate-induced gouty inflammation in mice.

Authors:  Qibin Yang; Quanbo Zhang; Yufeng Qing; Li Zhou; Qingsheng Mi; Jingguo Zhou
Journal:  Arthritis Res Ther       Date:  2018-07-11       Impact factor: 5.156

4.  MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.

Authors:  Huifang Lv; Honglin Hou; Huijun Lei; Caiyun Nie; Beibei Chen; Liangyu Bie; Lili Han; Xiaobing Chen
Journal:  Oncol Res       Date:  2019-12-03       Impact factor: 5.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.